Anti-IL11 Antibody (X203)

Synonyms: EnX203
Anti-IL11 Antibody (X203) (EnX203) 是一种人源抗人 IL-11 的 IgG1, κ 型抗体抑制剂,推荐同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。
Anti-IL11 Antibody (X203)
产品编号: MS-S38274 纯度: 98.53% 分子量: 145.96 kDa
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

Anti-IL11 Antibody (X203) (EnX203) 是一种人源抗人 IL-11 的 IgG1, κ 型抗体抑制剂,推荐同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

生物实验数据

生物活性 Anti-IL11 Antibody (X203) (EnX203) is a human anti-human IL-11 IgG1, κ antibody inhibitor, with the recommended isotype control being Human IgG1 kappa, Isotype Control (MS-E04981).
IC50 & Target

CDK1

 

ERK

 

STAT3

 

IL-11

 

E-cadherin

 

体外研究
(In Vitro)

Anti-IL11 Antibody (X203) (20 μM; 48 h) 可有效抑制 Bleomycin (MS-K75594) 诱导的小鼠髓核细胞中 IL-11 诱导的下游 STAT3 磷酸化。

Western Blot Analysis

Cell Line: Mouse nucleus pulposus (NP) cells treated with Bleomycin (40 μg/mL)
Concentration: 20 μM
Incubation Time: 48 h
Result: Effectively inhibited IL11–induced downstream STAT3 phosphorylation
体内研究
(In Vivo)

Anti-IL11 Antibody (X203) (20 mg/kg,腹腔注射,从 6 周龄开始每周两次,持续 2.5 周) 可改善 Alport 综合征 (AS) 小鼠模型的肾功能并延长其寿命。

Animal Model: Wild-type mice injected with BLM
Dosage: 20 mg/kg
Administration: i.p., alternate days from day 7 to 21 after BLM
Result: Showed no effect on overall survival.
Greatly reduced lung hydroxyproline content.
Reduced the expression of ECM-related genes.
Increased Mmp2/Timp1 ratio (a signature of preferential ECM remodeling) compared to control.
Markedly reduced ERK and SMAD activation whereas STAT3 phosphorylation remained elevated.
Animal Model: Wild-type mice injected with BLM
Dosage: 20 mg/kg
Administration: i.p., alternate days from day 14 to 28 after BLM
Result: Significantly reduced collagen deposition and parenchymal disruption, lung weights, and lung hydroxyproline content.
Had no effect on survival as compared to IgG treatment.
Reduced the expression of ECM proteins COL3A1 and fibronectin, as well as IL-11 levels in the lungs 28 days after BLM.
Markedly reduced ERK and SMAD activation whereas STAT3 phosphorylation remained elevated.
Animal Model: Col4a3-/- mice
Dosage: 20 mg/kg
Administration: i.p., twice a week for 2.5 weeks starting from 6 weeks of age
Result: Attenuated total body weight loss compared with the IgG group.
Significantly reduced kidney fibrosis.
Reduced renal ERK and STAT3 activation, fibrosis, and a signature of epithelial-to-mesenchymal transition.
Reduced SNA1 expression, central to EMT/pEMT, and restored E-cadherin levels while preserving podocyte numbers and expression of podocyte-specific proteins.
Induced substantial upregulation of renal cyclin D1 and PCNA expression associated with SNAI1 inhibition.
Prolonged lifespan in mice.
性状 液体
颜色 Colorless to light yellow

化学信息

分子量 145.96 kDa
别名 EnX203

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Shipping with dry ice.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础